Autoimmune thyroiditis in blood disease

Full Text

References

  1. Charcot M. Myxedeme, cachexie pachydermiqueon etet cretinoide. Gaz. Hop. Paris 1881; 54: 73.
  2. Axelrod A. R., Berman L. The bone marrow in hyperthyroidism and hypothyroidism. Blood 1951; 6: 436.
  3. Кассирский И. А., Алексеев Г. А. Клиническая гематология. М; 1970.
  4. Herbert V. Thyroid disease: disorders that cause hypothyroidism. The blood. In: Ingbar S. H., Braverman L. E., eds. Werner's the thyroid: A fundamental and clinical text. 5-th ed. Philadelphia; 1986. 1162-1168.
  5. Hall R., Scanlon M. F. Hyperthyroidism: Clinical features and complications. Clin. Endocrinol. Metab. 1979; 8: 29.
  6. Herbert V. Thyroid disease: disorders that cause thyrotoxicosis. The blood. In: Ingbar S. H., Braverman L. E., eds. Werner's the thyroid: A fundamental and clinical text. 5-th ed. Philadelphia; 1986. 878-884.
  7. Salvi M., Fukazawa H., Bernard N. et al. Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr. Rev. 1988; 9: 450-466.
  8. McKenzie J. M., Fenzi G. F., eds. Thyroid autoimmunity. New York: Plenum; 1987. 35-42.
  9. Weinberg K., Parkman R. Age, the thymus and T lymphocytes. N. Engl. J. Med. 1995; 332: 182-183.
  10. Volpe R. Autoimmunity in chronic thyroiditis. In: Klein F.,Horster F. A., eds. Autoimmunity in thyroid disease. Stuttgart: Schattaner - Verlag; 1979.
  11. Вольпе Р. Аутоиммунные заболевания щитовидной железы. В кн.: Браверман Л. И. (ред.) Болезни щитовидной железы. М.: Медицина; 2000. 140-172.
  12. Schubert M. F., Kountz D. S. Thyroiditis. A disease with many faces. Postgrad. Med. 1995; 98 (2): 101-103, 107-108.
  13. Santana V., Rose N. R. Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin. Immunol. Immunopathol. 1992; 63 (3): 205-213.
  14. Hashimoto H. Zur Kenntis der lymphomatosen Veranderung der Schiddruse (struma lymphomatosa). Arch. Klin. Chir. 1912; 97: 219-248.
  15. Volpe R. Autoimmune disease of the endocrine system. Boca Raton; CRC; 1990.
  16. Holm L. E., Blomgren H., Lowhagen T. Cancer risks in patients < with chronic lymphocytic thiroiditis. N. Engl. J. Med. 1985; ' 312 (10): 601-604.
  17. Mascovitz C, Dutcher J., Wiernik S. Association of thyroid disease with acute leucemia. Am. J. Haematol. 1992; 39 (3): 102-107.
  18. Takashima S., fkezoe J., Morimoto S. et al. Primari thyroid lymphoma: evaluation with CT. Radiology 1988; 168: 765- 767.
  19. Meissner W. A., Warren S. Tumor of the thyroid gland. Atlas of tumor pathology. Second series. Fasc 4. Washington: Armed Forces Institute of Pathology; 1969.
  20. Devine R. M., Edis A. J., Banks P. M. Primary lymphoma of the thyroid: A review of the Mayo Clinic experience through.1978. Wld J. Surg. 1981; 5: 33.
  21. Pedersen R. K., Pedersen N. T. Primary lymphoma of the thyroid gland: a population based study. Histopatology. 1996; 29: 25-32.
  22. Aozaka K., Ueda Т., Katagiri S. et ai. Immunologic and immunohistologic analysis of 27 cases with thyroid lymphomas. Cancer 1987; 60: 969-973.
  23. Aozaka K., Tajima K., Tominaga N. et al. Immunology and immunochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma. Oncology 1991; 48: 65- 71.
  24. Fenton J. E., Stack J., Kelly P., O'Dwyer T. P. Lymphoma and Hashimoto's thyroiditis. J. Laryngol. Otol. 1995; 109 (8): 781-783.
  25. Compagno J., Oertel J. E. Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am. J. Clin. Pathol. 1980; 74 : 1.
  26. Hyjek E., Isaacsson P. G. Primary В cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum. Pathol. 1988; 19: 1315-1327.
  27. Haciyanli M., Erkan N., Yorukoglu K. et al. Primary non- Hodgkin's T-cell lymphoma of the thyroid gland complicating Hashimoto's thyroiditis: case report. Thyroid 2000; 10 (8): 717-720.
  28. Hasegawa Y., Itoh Т., Tamagawa Y. et al. Non-Hodgkin's lymphoma followed by plasmacytoma, both arising in A thyroid gland with Hashimoto's disease. Leukemia, Lymphoma 1999; 35 (5-6): 613-618.
  29. Arullendran P., Pfleiderer A. G. Lymphoma arising from Hashimoto's thyroiditis: an unusual cause of acute stridor. Int. J. Clin. Pract. 1998; 52 (8); 588-589.
  30. Fehr-Merhof A., Flury R., Ruttimann S. From Hashimoto thyroiditis to B-cell lymphoma of the thyroid gland. Schweiz. Med. Wschr. 1999; 129 (23): 883-889.
  31. Burke J. S., Butler J. J., Fuller L. M. Malignant lymphomas of the thyroid: a clinical pathologic study of 35 patient including ultrastructural observations. Cancer 1977; 39: 1587-1602.
  32. Matsubayshi S., Tamai H, Morita T. et al. Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration. Clin. Exp. Immunol. 1990; 79: 170.
  33. Stott D. I., McLearie J., Neilson L. Analysis of the clonal origins of autoantibodies against thyroglobulin and DNA in autoimmune thyroiditis and systemic lupus erythematosus. Ibid. 1986; 65: 520.
  34. Karsenty G., Timsit J., Casadevall N. et al. Hashimoto's thyroiditis with intrathyroidal production of a monoclonal antithyroglobulin autoantibody. Ann. Endocrinol. (Paris) 1986; 47: 395.
  35. Виноградова Ю. Е., Виноградов Д. Л., Поверенный А. М.,Цыб А. Ф. Аутоиммунные тиреоидиты у больных некоторыми гематологическими заболеваниями. Тер. арх. 1994; 7: 65-68.
  36. Виноградова Ю. Е., Шинкаркина А. П., Поверенный А. М. Радиационное повреждение щитовидной железы как вероятная причина увеличения частоты неходжкинских лимфом и других гематологических заболеваний. Радиац. биол. радиоэкол. 1999; 39 (4): 431-433.
  37. Gupta S., Patel A., Folstad A. et al. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J. Clin. Endocrinol. Metab. 2001; 86 (3): 1346-1354.
  38. Di Pasquale M., Rothstein J. L., Palazzo J. P. Pathologic fea tures of Hashimoto's associated papillary thyroid carcinomas. Hum. Pathol. 2001; 32 (1): 24-30.
  39. Воробьев А. И., Кременецкая А. М., Лорие Ю. Ю. и др. "Старые" и "новые" опухоли лимфатической системы. Тер. арх. 2000; 72 (7): 9-13.
  40. Mahmoud /., Colin I., Many M., Dany J. Direct toxic effect iodine in exess an iodine-deficient thyroid glands. Exp. Mol. Pathol. 1986; 44: 259-271.
  41. Rose N. R., Saboori A. M., Rasooly L., Burek С L. The role of iodine in autoimmune thyroiditis. Crit. Rev. Immunol. 1997; 17 (5-6): 511-517.
  42. Weetman A. P., McGregor A. M. Autoimmune thyroid disease: further developments in our understanding. Endocrin. Rev. 1994; 15: 788-830.
  43. Авраменко H. Л. Функция щитовидной железы и специфические аутоиммунные реакции у детей Народического района Житомирской области спустя 2,5 года после аварии на Чернобыльской АЭС; Автореф. дис. канд. мед. наук. Обнинск; 1992.
  44. Шинкаркина А. П., Подгородниченко В. К., ПоверенныйA. М. Антитела к микросомальному антигену щитовидной железы у детей и подростков, подвергшихся радиационному воздействию в результате аварии на Чернобыльской АЭС. Радиац. биол., радиоэкол. 1994; 34 (1): 3-7.
  45. Касаткина Э. П., Шилин Д. Е., Матковская А. Н. и др. Радиационно-индуцированный патоморфоз эндемического зоба у детей и подростков в очаге йодного дефицита (начальные проявления отдаленных последствий Чернобыльской катастрофы). Пробл. эндокринол. 1995; 41 (3): 17- 23.
  46. Pinchera A., Fenzi G., Mariotti S. et al. Iodine and autoimmune thyroid disease. In: Iodine prophylaxic following nuclear accidents. Oxford: Pergamon Press; 1988. 39-44.
  47. Martin F. I. R., Tress B. W., Colman P. G., Dream D. R. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the eldery. Am. J. Med. 1993; 95: 78-82.
  48. Marino E., Safran M., Aghini-Zombordi F. et al. Enviromental iodine intake and thyroid dysfunction during chronic amiodaron therapy. Ann. Intern. Med. 1988; 101: 28-34.
  49. Sanisteban P., Hargreaves A., Cano J. et al. Effect of high doses of iodine on thyroid secretion: exidence for the presense of iodinated tubulin. Endocrinology 1985; 117: 607-612.
  50. Blagg С R. Antibodies to thyroglobulin in patients with thyrotoxicosis treated with radioactive iodine. Lancet 1960; 2 (7165): 1364-1366.
  51. Невструева М. А., Шубик В. М., Токин И. Б. Влияние инкорпоративных радиоизотопов на иммунологические процессы. М: Атомиздат; 1972.
  52. Шубик В. М., Липгвер Б. Я., Зыкова И. А. Характеристика некоторых показателей иммунитета у лиц, подвергшихся сочетанному воздействию факторов радиационной и нерадиационной природы. В кн.: Радиационная гигиена. Л.; 1978: 106-108.
  53. Поверенный А. М., Шинкаркина А. П., Подгородниченко B.К. и др. Иммунологические методы в эпидемиологическом мониторинге населения, подвергшегося воздействию радиоактивного йода в результате аварии на ЧАЭС. Радиобиология 1993; 33 [1 (4)]: 479-483.
  54. Poverenny A. M., Shinkarkina A. P., Podgorodnichenko V. К. et al. Sings of autoimmune thyroiditis in children and juveniles affected by the Chernobyl accident. Radiat. Protect. Dosimetry 1995; 62 (1/2): 75-76.
  55. Шинкаркина А. П., Жлоба А. А., Подгородниченко В. К. и др. Сравнительное изучение иммунологических (антимикросомальные антитела) и цитогенетических показателей у детей, проживающих на радиоактивно загрязненных территориях Брянской области. Радиац. биол., радиоэкол. 1997; 37 (3): 404-409.
  56. Clark D. E. Association of irradiation with cancer of the thyroid in children and adolescents. 3. A. M. A. 1955; 159: 1007- 1099.
  57. Duffy B. J., Fitzgerald P. J. Cancer of the thyroid in children: a report of 28 cases. J. Clin. Endocrinol. Metab. 1950; 10: 1296-1306.
  58. Conrad R. A., Dobyns В. М., Sutow W. W. Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout. J. AM. A. 1970; 214: 316-324.
  59. Scheider А. В., Bekerman C, Favus M. et al. Continuing occurrences of thyroid nodules after head and neck irradiation: relation to plasma thyroglobulin concentrations. Ann. Intern. Med. 1981; 94: 176-180.
  60. Scheider A. B. Radiation-induced thyroid tumors. Endocrinol. Metab. Clin. N. Am. 1990; 19: 495-508.
  61. DeGroot L. J., Paloyan E. Thyroid carcinoma and radiation, a Chicago endemic. J. A. M. A. 1973; 225: 487-491.
  62. Komorowski R. A., Hanson G. A. Morphologic changes in the thyroid following low-dose childhood radiation. Arch. Pathol. Lab. Med. 1977; 101 (1): 36-39.
  63. Spitalnik P. F., Straus F. H. 2d. Patterns of human thyroid parenchymal reaction following low-dose childhood irradiation. Cancer 1978; 41 (3): 1098-1105.
  64. DeGroot L. J., Hoye K., Refetoff S. et al. Serum antigens and antibodies in the diagnosis of thyroid cancer. J. Clin. Endocrinol. Metab. 1977; 45 (6): 1220-1223.
  65. DeGroot L. J., Reify M., Pinnamineni K., Refetoff S. Retrospective and prospective study of radiation-induced thyroid disease.Am. J. Med. 1983; 74: 852-862.
  66. Nagataki S., Shibata Y, fnoue S. et al. Thyroid diseases among atomic bomb survivors in Nagasaki. J. A. M. A. 1994; 272 (5): 364-370.
  67. Шнейдер А. Б., Рон Э. Облучение и рак щитовидной железы: итоги 46-летних исследований. В кн.: Браверман Л. И. (ред.) Болезни щитовидной железы. М.: Медицина; 2000. 288-313.
  68. Wick G., Boy D. R. Effector mechanism in thyroid autoimmune diseases. In: Klein E., Horster F. A., eds. Autoimmunity in thyroid diseases. Stuttgart: Schauttauer. -Verlag; 1979. 23- 29
  69. Eoviselli A., Oppo A., Velluzzi F. et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus С infection in the general population: results of a community-based study in north-western Sardinia. Endocrinol. Invest. 1999; 22 (9): 660-665.
  70. Wick G. Concept of a multigenic basis for the pathogenesis of spontaneous autoimmune thyroiditis. Acta Endocrinol. 1987; 115(suppl. 281): 63-64.
  71. Wenzel B. E., Heesemann J., Wenzel K. W., Schieber E. C. Antibody to plasmid-encoated protein of enteropathic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; 1: 56.
  72. Wenzel B. E., Heesemann J., Heufelder A. et al. Enteropathogenic Yersinia enterocolitica and organ-specific autoimmune diseases in man. In: Une Т., Maruyama Т., Tsubokura M., eds. Current investigation of the microbiology of Yersiniae. (Contrib. Microbiol. Immunol. Vol. 12). Basel: Karger; 1991. 80-88.
  73. Tomer Y., Davies T. F. Infection, thyroid disease and autoimmunity. Endocr. Rev. 1993; 14: 107-120.
  74. Krieg A. M., Steinberg A. D. Review: Retroviruses and autoimmunity. J. Autoimmun. 1990; 3: 137-166.
  75. Volpe R. A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder? Autoimmunity 1992; 12: 3-9.
  76. Wilkin T. J. The primary lesion theory of autoimmunity: a speculative hypothesis. Ibid. 1990; 7: 225-235.
  77. Wick G., Muller P. U., Kuhn L., Lefkovits I. Molecular analysis of genetically determined target cell abnormalities in spontaneous autoimmune thyroiditis. Immunobiology 1990; 181: 414- 429.
  78. Khan L. В., Dale J. Virus-like particles in Hashimoto's disease and a variety of other tissues. Lab. Invest. 1973; 29: 350.
  79. Custro N., Montalto G., Scafldi V. et al. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis С and interferon therapy. J. Endocrinol. Invest. 1997; 20 (7): 374-380.
  80. Rocco A., Gargano S., Provenzano A. et al. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis С virus infection. Neuroendocrinol. Lett. 2001; 22 (1): 39-44.
  81. Minelli R., Braverman L. E., Giuberti T. et al. Effects of excess iodine administration on thyroid function in euthyroid patient swith a previuse episode of thyroid dysfunction induced by in terferon-alpha treatment. Clin. Endocrinol. 1997; 47 (3): 357- 361.
  82. Vassilopoulou-Sellin R., Sella A., Dexeus F. H. et al. Acute thyroid dysfunction (thyroiditis) after therapy with interleukin-2. Horm. Metab. Res. 1992; 24: 434-438.
  83. Nelson I. L., Steinberg A. D. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I., Kovaks K. eds. Hormones and immunity. Lancaster: MTP Press; 1987. 93-119.
  84. Weetman A. P. Autoimmune thyroiditis: predisposition and pathogenesis Clin. Endocrinol. 1992; 36: 307-323.
  85. Rose N. R., Bacon L. D., Sundick R. S, Kong Y. M. The role of genetic factors in autoimmunity. In: Meisher P. A., BolisL., Gorini S. et al., eds. The Menarini series of immunopathology - First Symposium on organ-specific autoimmunity. Basel: Schwabe; 1978. 225-233.
  86. Dawe К, Hutchings P., Champion В. et al. Autoantigens in thyroid disease. Springer Semin. Immunopathol. 1993; 14: 285- 307.
  87. Ludgate M., Vassart G. The molecular genetics of three thyroid autoantigens: thyroglobulin, thyroid peroxidase and the thyrotrophin receptor. Autoimmunity 1990; 7: 201-211.
  88. Cuddihy R. M., Dutton С. M., Bahn R. S. A polymorphism in the extracellular domain of the thyrotropin receptor is highly, associated with autoimmune thyroid disease in females. Thyroid 1995; 5: 89-95.
  89. Doniach I. F. Aetiological consideration of thyroid cancer. Br.J. Radiol. 1971; 44: 819.
  90. Volpe R. Immunology of human autoimmune thyroid disease.In: Volpe R., ed. Autoimmunity diseases of the endocrine system. Boca Raton. Florida: CRC Press; 1990. 73-240.
  91. Dames T. F., Platzer M. The T-cell supressor defect in autoimmune thyroiditis: Evidence for a high set "immunostat". Clin. Exp. Immunol. 1986; 63: 73-78.
  92. Davies T. F. Cocultures of human thyroid monolayer cells and autologous T-cells: Impact of HLA class II antigen expression. J. Clin. Endocrinol. Metab. 1985; 61: 418-422.
  93. Zhang H., Li D., Ouyang A. An immunohistochemical study on human leukocyte antigen-DR in Hashimoto thyroiditis and Graves disease. Chung Hua Nei Ко Tsa Chih. 1996; 35 (5): 303-305.
  94. Chiovato L., Lapi P., Mariotti S. et al. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma. J. Clin. Endocrinol. Metab. 1994; 79 (2): 653-656.
  95. Iwatani Y, litaka M., Row V. V, Volpe R. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Clin. Invest. Med. 1988; 11: 279-285.
  96. Weetman A. P. Review: Antigen presentation in the pathogenesis of autoimmune endocrine disease. J. Autoimmun. 1995; 8: 305-312.
  97. Weetman A. P. The immunoregulatory effects of antithyroid drugs. Thyroid 1994; 4: 145-146.
  98. Irvin W. J., Grey R. S., McCallum С J. Pancreatic islet cell antibody as a marker for asymptomatic and latent diabetes and prediabetes. Lancet 1976; 2: 1097.
  99. Farid N. R., Sampson L., Moens H., Barnard J. M. The association of gouitrous autoimmune thyroiditis with HLA-DR. Tissue Antigens 1981; 17: 265-268.
  100. Badenhoop K, Walfish P. G., Rau H. et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.J. Clin. Endocrinol. Metab. 1995; 80 (7): 2112-2117.
  101. Weetman A. P., So A. K, Roe С et al. T cell receptor a-chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves disease. Hum. Immunol. 1987; 20: 167-173.
  102. Katzin W., Fishleger A., Tubbs R. Investigation of the clonality of lymphocytes in Hashimoto thyroiditis using immunoglobulin and T-cell receptor gene probes. Clin. Immunol. Immunopathol. 1989; 51: 264-269.
  103. Ewins D. L., Rossor M. N., Butler J. et al. Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin. Endocrinol. 1991; 35: 93-96.
  104. Kawasaki Eiji, Nirio Abiru, Mayumi Yano et al. Autoantibody to glutamic acid decarboxilase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodiesJ. Autoimmun. 1995; 8: 633-643.
  105. Doniach D., Roitt I. M. An evaluation of gastric and thyroid autoimmunity in relarion to hematologic disorders. Semin. Hematol. 1964; 1: 313-315.
  106. Doniach D., Roitt [. M., Taulor К. В. Autoimmunity in pernicious anemia and thyroiditis: a family study. Ann. N. Y. Acad. Sci. 1965; 124: 605.
  107. Witebsky E., Rose N. R. Studies on organ specificity. IV. Productuion of rabbit thyroid antibodies in the rabbit. J. Immunol. 1956; 76: 408-416.
  108. Baker B. A., Gharib H., Markowitz H. Correlation of thyroid antibodies and cytologic features in suspected autoimmune thyroid disease. Am. J. Med. 1983; 74: 941-944.
  109. Roitt I. M., Campbell P. N., Doniach D. The nature of the thyroid autoantibodies present in patients with Hashimoto's thy roiditis (lymphadenoid goitre). Biochem. J. 1958; 69: 248- 256.
  110. Holborov E. J., Brown P. C, Roitt I. M., Doniach D. Cytoplasmic localization of complement fixing auntigen in human thyroid epithelies. Br. J. Exp. Pathol. 1959; 40: 583.
  111. Beljavin G., Trotter W. Investigation of thyroid antigens reacting with Hashimoto sera. Lancet 1959; 1: 648-652.
  112. McLachlan S. M., Rapoport B. Autoimmune endocrinopaties 2. Recombinantthyroid autoantigens the keys to the pathogenesis of autoimmune thyroid disease. J. Intern. Med. 1993; 234: 347-359.
  113. Pinchera A., Mariotti S., Vitti P. et al. Thyroid autoantigens and their relevance in the pathogenesis of thyroid autoimmunity. Biochimie 1989; 71 (2): 237-245.
  114. Fisher D. A., Beall G. N. Hashimoto's thyroiditis. Pharmacol. Ther. 1976; 1: 445-458.
  115. Fisher D. A., Bell G. N. Hashimoto's thyroiditis. In: Hershman J. M., Bray G. A., eds. The thyroid: physiology and treatment of disease. International encyklopedia of pharmacology and therapeutics. Oxford, Pergamon Press; 1979. Sect. 101.
  116. Yoshida H., Amino N., Yagama K. et al. Association of serum antithiroid antibodies with lymphoid infiltration of the thyroid gland. J. Clin. Endocrinol. Metab. 1978; 46: 859-862.
  117. П. Amino N., Hagan S. R., Yamada N., Pefetoff S. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin. Endocrinol. (Oxf). 1976; 5: 115-125.
  118. Cayzer L, Chalmers S. R., Doniach D., Swana G. An evaluation of two new haemagglutination tests for rapid diagnosis of autoimmune thyroid disease. J. Clin. Pathol. 1978; 31: 1147- 1151.
  119. Schuppert F., Reiser M., von zur Mtihlen A. TSH-receptor and adhesion molecules in autoimmune thyroid disease. Exp. Clin. Endocrinol. 1992; 100: 28-31.
  120. Weetman A. P., McGregor A. M. Autoimmune thyroid disease: developments in our understending. Endocr. Rev. 1984; 5: 309-355.
  121. Amino N., Mori H., Iwatani Y. et al. Significance of thyroid microsomal antibodies. Lancet 1980; 2: 1369.
  122. Banga J. P., Barnett P. S., McGregor A. M. Immunological and molecular characteristics of the thyroid peroxidase autoantigen. Autoimmunity 1991; 8: 335-343.
  123. Engler H., Riesen W. F., Keller В. Diagnostic value of autoanti- bodies against microsome thyroid peroxidase (anti-TPO). Schweiz. Med. Wschr. 1992; 122 (51-52): 1976-1980.
  124. Massart C, Guilhem /., Gibassier J. et al. Comparison of thyroperoxidase and microsomal antibody assays in sera from patients with Grave's disease. Clin. Chem. 1991; 37 (10, pt 1): 1777-1780.
  125. Kohno Y, Yamaguchi F., Saito K. et al. Anti-thyroid peroxidase antibodies in sera from healthy subjects and from patients with chronic thyroiditis: differences in the ability to inhibit thyroid peroxidase activities. Clin. Exp. Immunol. 1991; 85 (3): 459- 463.
  126. Mariotti S., Caturegli P., Barbesino G., Pinchera A. Antithyroid peroxidase autoantibody in thyroid disease. J. Clin. Endocrinol. Metab. 1990; 71: 661-669.
  127. Naito N., Saito K., Hosoya T. et al. Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: differences in cross-reactivity with thyroid peroxidase. Clin. Exp. Immunol. 1990; 80(1): 4-10.
  128. McLachlan S. M., Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role a autoantigen in autoimmune thyroid disease. Endocr. Rev. 1992; 13: 192-206.
  129. Zophel K, Gruning Т., Wunderlich G., Franke W. G. Clinical value of a bispecific antibody binding to thyroglobulin and thyroperoxidase (TGPO-aAb) in various thyroid diseases. Autoimmunity 1999; 29: 257-262.
  130. Volpe R. Autoimmunity in thyroid disease. In: Volpe R., ed. Autoimmunity in endocrine disease. New York: Dekker; 1985. 109-286.
  131. Hazard J. B. Thyroiditis: A review. Am. J. Clin. Pathol. 1955; 25: 289-298, 399-426.
  132. Ahmann A. J., Barman K. D. The role of T-lymphocytes in autoimmune thyroid disease. Endocrinol. Metab. Clin. N. Am. 1987; 16: 287-326.
  133. Cho B. Y, Shong Y. K, Lee H. K. et al. Inhibition of thyrotropin stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL5, by immunoglobulin G from patients with primary myxedema: Comparison with actvities of thyrotropin binding inhibitor immunoglobulin. Acta Endocrinol. 1989; 120: 99-106.
  134. Bogner U., Schleusener H., Wall J. Antibody-dependent cellmediated cytotoxicity against human thyroid cells in Hashimoto thyroiditis but not Greave's disease. J. Clin. Endocrinol. Metab. 1984; 59: 734-738.
  135. Grubeck-Loebenstein В., Onvi M., Greenoail С et al. Stimulatory activities of antigen presenting cells in mixed leukocyte reactions in thyroid diseases. Acta Endocrinol. 1987; 115 (suppl. 281): 211-219.
  136. Aguayo J., Sakatsume Y., Jamieson C. et al. Non-toxic goiter and papillary carcinoma of the thyroid are not associated with peripheral blood sensitization to thyroid cells. J. Clin. Endocrinol. Metab. 1989; 68: 145-149.
  137. Sakatsume Y., Matsubayashi S., Kasuga Y. et ai. Lack of response of peripheral blood mononuclear cells to thyroid microsomal antigen in non-toxic nodular goitre. Region. Immunol. 1990; 3: 42-45.
  138. Aust G., Lehmann I., Heberling H. J. Different immunophenotype and autoantibody production by peripheral blood and thyroidderived lymphocytes in patients with Grave's disease. Exp. Clin. Endocrinol. Diabet. 1996; 104 (1): 50-58.
  139. Landay A., Gartland G. L., Clement L. T. Characterization of a phenotypical subpopulation of Leu-2 cells that suppresses T cell proliferative responses. J. Immunol. 1983; 131: 2757- 2761.
  140. Kassian M. Т., Ikermatsu H., Casali P. CD5+ В lymphocytes. Proc. Soc. Exp. Biol. (N. Y.) 1991; 197: 226-241.
  141. Iwatani Y., litaka M., Row V. V. et al. Induction of thyroid autoantibody production: synergistic effect of В cell mitogen combined with T cell mitogen, i. Clin. Endocrinol. Metab. 1987; 65: 853-861.
  142. Wenzel B. E., Heesemann J., Wenzel K. W., Schieber E. C. Antibody to plasmid-encoated protein of enteropathic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; 1: 56.
  143. Rose N. R., Bacon L. D., Sundick R. S., Kong Y. M. The role of genetic factors in autoimmunity. In: Meisher P. A., BolisL., Gorini S. et al., eds. The Menarini series of immunopathology - First Symposium on organ-specific autoimmunity. Basel: Schwabe; 1978. 225-233.
  144. Bohr U. R. M., Behr M., Loos U. A heritable point mutation in an extracellular domain on the TSH receptor involvedin the interection with Grave's immunoglobulins. Biochim. Biophys. Acta 1993; 1216: 504-508.
  145. Doniach D., Roitt I. M., Taulor К. В. Autoimmunity phenomena in pernicious anemia. Br. Med. J. 1963; 1: 313.
  146. Weetman A. P., Walport M. J. The association of autoimmune thyroiditis with systemic lupus erythematosus. Br. J. Rheum. 1987; 25 (5): 359-361.
  147. Scuderi F. The Association of silent thyroiditis with active systemic lupus erythematosus. Clin. Exp. Rheum. 1992; 10 (1): 67-70.
  148. Goh K. L., Wang F. Thyroid disorders in systemic lupus erythematosus. Ann. Rheum. Dis. 1986; 45 (7): 579-583.
  149. Серебряков В. Г., Аликберова 3. С. Клинико-лабораторные особенности системной красной волчанки в сочетании с патологией щитовидной железы. Ревматология 1990; 8: 13-17.
  150. Подчерняева Н. С, Шилин Д. Е., Караштина О. В. и др. Патология щитовидной железы при системной красной волчанке у детей. Дет. ревматол. 1997; 2: 25-31.
  151. Воробьев А. И., Бриллиант М. Д. О разных популяциях эритроцитов при некоторых анемических состояниях. В кн.: Вопросы биофизики, биохимии и патологии эритроцитов. Красноярск; 1961. 226-234.
  152. Воробьев А. И., Чертков И. Л., Бриллиант М. Д. Кроветворение. В кн.: Воробьев А. И. (ред.) Руководство по гематологии. М.: Медицина; 1985. 22-43.
  153. Идельсон Л. И. Анемии. В кн.: Руководство по гематологии. 2-е изд. М.; 1985; т. 2: 94-121.
  154. Пивник А. В., Идельсон Л. И., Воробьев В. Г. и др. Эритромиелоз в исходе парциальной красноклеточной аплазии. Тер. арх. 1986; 9: 97-99.
  155. Тер-Григоров В. С, Граф И. А., Ивлева Е. С. и др. Антитела против межвидового антигена эритрокариоцитов у больных парциальной красноклеточной аплазией костного мозга. Бюл. экспер. биол. 1980; 10: 459-461.
  156. Эткин А. Ф., Тер-Григоров В. С, Пивник А. В. и др. Аутоантитела против межвидового антигена эритрокариоцитов при анемиях и гемобластозах. Тер. арх. 1984; 6: 99- 103.
  157. Tadmor В., Putterman С, Naparstek Y. Embrional germlayer antigens: target for autoimmunity. Lancet 1992; 339: 975-978.
  158. Langman J. Medical embryology. 6"' ed. Baltimore: Williams & Wilkins; 1988.
  159. Rougon G., Marshak D. Structural and immunological characterization of the amino-terminal domain of mammalian neural cell adhesion molecues. J. Biol. Chem. 1986; 261: 3396- 3401.
  160. Negeles J., Boucraut J., Gamier J. M. et al. Evidence for autoimmune antibodies directed against neural cell adhesion molecules (N-CAM) in patient with group B. Meningitis. J. Neuroimmunol. 1990; 29: 49-56.
  161. Bottaszzo G. L., Pujok-Borrell R., Hanafusa T, Feldmann M. Role aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 115- 119.
  162. Mendelsohn J., Prinsiples of neoplasia. In: Braunwald E., Isselbacher K., Petersdorf R. et al., eds. Harrison's principles of internal medicine. 11"' ed. New York: McGraw-Hill; 1988. 430-431.
  163. Okada Y., Tsuj I. Neoexpression of sialyl oligimeric Lewis X by Kupffer cells in chronic hepatitis. Lancet 1990; 335: 1302- 1306.
  164. Wool/ P. D. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr. Rev. 1980; 1: 411-420.
  165. Hasckett E., Beech M., Forbes I. J. Thyroglobulin antibodies in patients without clinical disease of the thyroid gland. Lancet 1960; 2: 402-404.
  166. Hujmans W., Radl J., Bottazo G. F., Doniach D. Autoantibodies in highly aged humans. Mech. Ageing Dev. 1984; 26: 83-89.
  167. Tomer Y. K. Shonfeld Y. Ageing and autoantibodies. Autoimmunity 1988; 1: 141-149.
  168. Furszyfer J., Kerland L. Т., Macconahey W. M. et al. Epidemiologic aspects of Hashimoto's thyroiditis Grave's disease in Rochester, Minnesota (1935-1967). With special reference to temporal trends. Metabolism 1972; 21: 197.
  169. Hawkins B. R., Cheah P. S., Dawkins R. L. Diagnostic sigificance of thyroid microsomal antibodies in a randomly selected population. Lancet 1980; 2: 1057.
  170. Hawkins B. R., O'Connor K. J., Dawkins R. L. et al. Autoantil bodies in an Australian population. I. Prevalence and presist-ence. J. Clin. Lab. Immunol. 1979; 2: 211.
  171. Naito N., Saito K., Hosoya T. et al. Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: differences in cross-reactivity with thyroid peroxidase. Clin. Exp. Immunol. 1990; 80 (1): 4-10.
  172. Le Boef G., Bongiovanni A. M. Thyroiditis in childhood. Adv. Pediatr. 1964; 13: 183.
  173. Tunbridge W. M. G. The epidemiology of hypothyroidism. Clin. Endocrinol. Metab. 1979; 8(1): 21-26.
  174. Volpe R. Autoimmune thyroid disease. In: Volpe R., (ed.) Autoimmunity and endocrine diseases. New York: Marcel Dekker; 1985. 109-285.
  175. Villi P., Mariotti S., Marcocci С et al. Thyroid autoimmunity and thyroid autonomy. Acta Med. Aust. 1990; 17 (suppl. 1): 90-92.
  176. Tunbridge W. M. G. Is hypothyroidism causing your patient's lethargy? Geriatrics 1981; 36(1): 79-82.
  177. Denham M. Y., Wills E. J. A clinico-pathological survey of thyroyd glands in old age. Gerontology, 1980; 26: 160.
  178. Wyse E. P., McCowahey W. M., Woodlner L. B. et al. Ophthalmopathy wihout hyperthyroidism in personus with histological Hashimpoto's thyroiditis. J. Clin. Endocrinol. Metab. 1968; 28: 1623.
  179. Gryfe C, Wolfish P. G. Testig your older patients thyroid function. Geriatrics 1982; 37: 135.
  180. Mariotti S., Sanson! P., Barbesino G. et al. Thyroid and other organspecific autoantibodies in healthy centenarians. Lancet 1992; 339: 1506-1508.
  181. Ami Т., Kurashima C, Utsuyama M. et al. Measurement of antithyroglobulin and anti-thyroid peroxidase antibodies using highly sensitive radioimmunoassay: an effective method for detecting asymptomatic focal lymphocytic thyroiditis in the elderly. Endocr. Jpn. 2000; 47 (5): 575-582.
  182. Doniach D. Hashimoto's thyroidits and primary myxoedema vieved as separate entities (editouial). Eur. J. Clin. Invest. 1981; 11:245.
  183. Deodhar S. D. Autoimmune disease: Overview and current concepts of pathogenesis. Clin. Biochem. 1992; 25: 181 - 185.
  184. Ardeman S., Chanarin I., Krafchick В., Singer W. Addisonian pernicious anaemia and intrinsic factor antibodies in thyroid disorders. Quart. J. Med. 1966; 35: 421.
  185. Неппетапп Н. Н., Kloss A. Autommune haemolytic anaemia, thhrombocytopenia and thyroiditis: an immunopathological triad (author's transl.). Dtsch. Med. Wschr. 1978; 103 (14): 609-612.
  186. Ogihara Т., Katoh H., Yoshitake H. et al. Hyperthyroidism associated with autoimmune hemolytic anemia and periodic paralysis: a report of a case in which antihyperthyroid therapy alone was effective against hemolysis. Jpn. J. Med. 1987; 26 (3): 401-403.
  187. O'Brien D., Lyons D. J., Fielding J. F. A case of Grave's disease associated with autoimmune haemolytic anaemia. Ir. J. Med. Sci. 1989; 158 (6): 155.
  188. Afeltra A., Paggi A., De Rosa F. G. et al. Antineutrophil cytoplasmic antibodies in autoimmune thyroid disorders. Endocr. Res. 1998; 24 (2): 185-194.
  189. Freire B. A., Paula I. D., Kallenberg С G. et al. Absence of cross-reactiivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases. Am.J. Med. Sci. 2001; 321 (2): 109-112.
  190. Sato H., Hattori M., Fujieda M. et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset i Glave's disease trated with propylthiouracil. J. Clin. Endocrinol. Metab. 2000; 85 (11): 4270-4273.
  191. Yashiro M., Nagoshi H., Kasuga Y. et al. Evans' syndrome associated with Grave's disease. Intern. Med. 1996; 35 (12): 987-990.
  192. Lio S., Albin M., Girelli G. et al. Abnormal thyroid function test results in patients with Fisher-Evans syndrome. J. Endocrinol. Invest. 1993; 16 (3): 163-167.
  193. Romaldini J. H., Biancalana M. M., Figueiredo D. I. et al. Ef- fect of L-thyroxine administration on antithyroid antibody level, lipid profile, and thyroid volume in patients with Hashimo- to's thyroiditis. Thyroid 1996: 6 (3): 183-188.
  194. Maugendre D., Gate! A., Campion L. et al. Antithyroid drugs and Grave's disease-prospective randomized assessment of longterm treatment. Clin. Endocrinol. (Oxf.) 1999; 50 (1): 127-132.
  195. Поверенный А. М., Шинкаркина А. П., Виноградова Ю. Е. и др. Вероятные последствия повреждения радиоактивным йодом щитовидной железы в период Чернобыльской аварии. Радиац. биол., радиоэкол. 1996; 36 (4): 632-640.

Statistics

Views

Abstract: 177

Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2003 Vinogradova Y.E., Shinkarkina A.P., Poverenny A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies